Rose Li And Associates, Inc.

Rose Li And Associates, Inc., doing business as Rose Li & Associates Inc., is an Economically Disadvantaged Women-Owned Small Business (EDWOSB) and 8(a) Program Participant that provides research administration, scientific management, event support, and communications services to federal health and research agencies as a prime contractor on 98% of recent awards. Headquartered in Bethesda, Maryland, the company is a Subchapter S corporation, minority-owned (Asian-Pacific American), and self-certified as a small disadvantaged business; it competes predominantly under 8(a) and women-owned small business set-asides.

Rose Li's customer base concentrates heavily in the Department of Health and Human Services ecosystem. The top five customer agencies account for 67% of recent awards by count, anchored by the National Institute on Aging (41 awards, $13.9 million), the HHS Office of the Assistant Secretary for Administration (30 awards, $54 million), and the National Institute on Drug Abuse (27 awards, $19.8 million), with the National Cancer Institute and the Office of the Director rounding out the active set. By potential value, however, the rankings diverge dramatically due to Rose Li's seat on the GSA 8(a) STARS III Government-Wide Acquisition Contract (a $50 billion ceiling awarded June 28, 2022, expiring July 1, 2026), which carries $50 billion in combined potential value as a governmentwide IT services vehicle for all federal agencies — though the source shows minimal actual task-order activity drawn against it. Excluding that placeholder ceiling, HHS Office of the Assistant Secretary for Administration work dominates dollar concentration.

Rose Li's concrete capability footprint reflects its award history: science management and research administration support for federal research initiatives; meeting logistics, event planning, and symposium coordination across health agencies; technical writing and communications; federal advisory committee support; and program management services. Representative prime work includes a $5.1 million Woman-Owned Small Business sole-source purchase order with HHS Office of the Assistant Secretary for Financial Resources (awarded September 2026) for research misconduct oversight and program support; a $3.8 million 8(a) sole-source definitive contract with HHS Office of the Assistant Secretary for Financial Resources (awarded September 2023) for new regulation implementation support; a $2.7 million 8(a) sole-source definitive contract with HHS Office of Infectious Disease (awarded September 2023) for materials development and meeting support; a $2.7 million 8(a) sole-source purchase order with the National Institute on Drug Abuse (awarded March 2022) for logistical support to the Summer Research Internship Program; and a $1.8 million 8(a) sole-source definitive contract with the National Institute on Drug Abuse (awarded March 2022) for meeting logistics supporting the National Institute of Mental Health's Office of Autism Research Coordination. The company also holds two large indefinite delivery vehicles with HHS components: a $6.5 million single-award Competitive 8(a) IDC with the National Institute on Aging (awarded September 2023, through August 2028) for science management and research administration, and a $23.9 million single-award Competitive 8(a) BPA with the Office of the Assistant Secretary for Administration (awarded August 2023, through June 2028) for logistical services including meetings, conferences, travel, and administrative support.

Rose Li's SCI-reported federal service contract activity shows invoiced revenue of $35.3 million across FY2022–FY2025, with growth from $5.8 million in FY2022 to a peak of $12.3 million in FY2024, declining to $8.5 million in FY2025. The FTE trajectory expanded from 12.0 FTEs in FY2022 to 23.9 in FY2024, then contracted to 18.4 FTEs in FY2025. Government-paid hourly rates on SCI-reportable contracts run a median of $173.08/hr, with senior labor pricing (90th percentile) reaching $581.54/hr. On the GSA Multiple Award Schedule, Rose Li carries 77 active labor categories spanning $53.24–$474.64/hr — from Junior Project Assistant (high school, no experience) through Senior Subject Matter Expert (master's degree, nine years' experience) — with no cleared or security-focused roles offered. Across SCI-reportable prime contracts, Rose Li self-performs approximately 98% of delivered hours with no subcontractor engagement, indicating a wholly owned delivery model rather than a subcontracting-dependent posture.

Activity has been volatile year-to-year: 22 awards in 2022, spiking to 33 in 2023, falling to 23 in 2024, and declining sharply to 5 in 2025 and 6 in 2026 as of early October. Fifteen awards worth $23 million face ultimate completion inside the next twenty-four months and therefore carry recompete exposure. Rose Li's subcontractor footprint is minimal; the vendor functions as a subcontractor to Leidos Inc. on Defense Health Agency research support and administrative services work and to Booz Allen Hamilton Inc. on Office of Research on Women's Health communications and logistics support. These represent exception roles rather than a core teaming pattern. Set-aside designation recurs across Rose Li's prime footprint: approximately 45% of awards by count carry Competitive 8(a) or 8(a) Sole Source designations; the remainder compete full-and-open or under women-owned small business and total small business set-asides on the GSA MAS. The company's participation in the 8(a) STARS III GWAC provides access to governmentwide IT procurement channels, though recent award data show limited task-order leverage of that vehicle relative to HHS-focused delivery orders and BPA calls.

Rose Li and Associates, Inc. (RLA) is a woman- and minority-owned small business professional services company that uses its multidisciplinary expertise to provide professional science writing services in a variety of content areas; prepare state-of-the-science assessments that often signal where future research investments should be made; help clients plan and staff scientific meetings; and manage committees, projects, and scientific reviews. Since our inception in July 2003, RLA has provided professional services support to the National Institutes of Health (NIH), other Federal agencies, and private and non-profit entities. A listing of current and past clients can be found at www.RoseLiAssociates.com. RLA is reputed for its high-quality work, and is adept at matching the appropriate expertise needed for the task at hand, conducting cost-conscious management of contracts, and meeting demanding time lines.